Limitation of collagen cross-linking with hypoosmolar riboflavin solution: failure in an extremely thin cornea
- PMID: 21389853
- DOI: 10.1097/ICO.0b013e31820143d1
Limitation of collagen cross-linking with hypoosmolar riboflavin solution: failure in an extremely thin cornea
Abstract
Purpose: We report a case of failure of corneal collagen cross-linking (CXL) for progressive keratoconus after preoperative stromal swelling with hypoosmolar riboflavin solution in an extremely thin cornea.
Methods: CXL was performed using the protocol established for the treatment of thin corneas. Preoperative minimal thickness after abrasion was 268 μm and increased to 406 μm after swelling with hypoosmolar riboflavin solution.
Results: Despite CXL, a distinct progression of up to 1.9 diopters was observed at 3 months after the procedure on the anterior corneal surface. At 6 months after CXL, progression had increased to 2.3 diopters. Although swelling with hypoosmolar riboflavin solution was effective and led to a preoperative thickness of more than 400 μm, the increase in biomechanical resistance was not sufficient to arrest the progression of the disease.
Conclusions: Little is known about the minimal stromal thickness required for effective CXL to occur. Although swelling with hypoosmolar riboflavin solution over 400 μm and safety of the procedure can be achieved in even thinner corneas, the outcome of this case suggests that a minimal preoperative stromal thickness of 330 μm needs to be respected for a successful CXL procedure.
Similar articles
-
Collagen crosslinking with ultraviolet-A and hypoosmolar riboflavin solution in thin corneas.J Cataract Refract Surg. 2009 Apr;35(4):621-4. doi: 10.1016/j.jcrs.2008.10.060. J Cataract Refract Surg. 2009. PMID: 19304080
-
Corneal collagen cross-linking with riboflavin and ultraviolet-A irradiation in patients with thin corneas.Am J Ophthalmol. 2012 Jan;153(1):24-8. doi: 10.1016/j.ajo.2011.05.036. Epub 2011 Sep 8. Am J Ophthalmol. 2012. PMID: 21861976
-
Clinical and corneal biomechanical changes after collagen cross-linking with riboflavin and UV irradiation in patients with progressive keratoconus: results after 2 years of follow-up.Cornea. 2012 Jun;31(6):609-14. doi: 10.1097/ICO.0b013e318226bf4a. Cornea. 2012. PMID: 22378112 Clinical Trial.
-
Crosslinking treatment of progressive keratoconus: new hope.Curr Opin Ophthalmol. 2006 Aug;17(4):356-60. doi: 10.1097/01.icu.0000233954.86723.25. Curr Opin Ophthalmol. 2006. PMID: 16900027 Review.
-
Long-term results of cornea collagen cross-linking with riboflavin for keratoconus.Indian J Ophthalmol. 2013 Aug;61(8):433-4. doi: 10.4103/0301-4738.116072. Indian J Ophthalmol. 2013. PMID: 23925332 Free PMC article. Review.
Cited by
-
A short-term study of corneal collagen cross-linking with hypo-osmolar riboflavin solution in keratoconic corneas.Int J Ophthalmol. 2015 Feb 18;8(1):94-7. doi: 10.3980/j.issn.2222-3959.2015.01.17. eCollection 2015. Int J Ophthalmol. 2015. PMID: 25709915 Free PMC article.
-
Bowman layer transplantation: 5-year results.Graefes Arch Clin Exp Ophthalmol. 2018 Jun;256(6):1151-1158. doi: 10.1007/s00417-018-3927-7. Epub 2018 Feb 14. Graefes Arch Clin Exp Ophthalmol. 2018. PMID: 29445872
-
Patient selection for corneal collagen cross-linking: an updated review.Clin Ophthalmol. 2017 Apr 7;11:657-668. doi: 10.2147/OPTH.S101386. eCollection 2017. Clin Ophthalmol. 2017. PMID: 28435217 Free PMC article. Review.
-
A review of collagen cross-linking in cornea and sclera.J Ophthalmol. 2015;2015:289467. doi: 10.1155/2015/289467. Epub 2015 Apr 2. J Ophthalmol. 2015. PMID: 25922758 Free PMC article. Review.
-
Current concepts in crosslinking thin corneas.Indian J Ophthalmol. 2019 Jan;67(1):8-15. doi: 10.4103/ijo.IJO_1403_18. Indian J Ophthalmol. 2019. PMID: 30574883 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources